MOVING THE NEEDLE FOR CELL THERAPIES: A NEXT-GENERATION EX VIVO PLATFORM USING NANONEEDLES FOR PRECISION CARGO DELIVERY

被引:0
|
作者
Syed, N. [1 ]
Narasimha, A. [1 ]
Webb, M. [1 ,2 ]
Lesnik, J. [1 ]
Vishwanathan, G. [1 ]
Otto, L. [1 ]
Chooljian, M. [1 ]
Tahmasebipour, A. [1 ]
Aluri, V. [1 ]
Preetam, S. [1 ]
Chow, Y. [1 ]
Nguyen, C. [1 ]
Pietropaoli, L. [1 ]
Higley, S. [1 ]
Masterson, T. [1 ]
Onikoyi, J. Adetunji [1 ,2 ]
Steele, D. [1 ]
Chou, E. [1 ]
Tondar, A. [1 ]
Goetesh, L. [1 ]
机构
[1] Mekonos Inc, San Francisco, CA USA
[2] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA
关键词
Cell therapy; Non-Viral; Immune Cells;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
1231
引用
收藏
页码:S270 / S271
页数:2
相关论文
共 17 条
  • [11] Next-generation ex-vivo gene editing of human hematopoietic stem cells by optimized delivery platforms and selection of cells bearing the intended edits
    Ferrari, S.
    Jacob, A.
    Fiumara, M.
    Vavassori, V.
    Cesana, D.
    Canarutto, D.
    Laugel, M.
    Varesi, A.
    Beretta, S.
    Conti, A.
    Omar-Javed, A.
    Albano, L.
    Calabria, A.
    Cipriani, C.
    Castiello, M. C.
    Esposito, S.
    Adjali, O.
    Ayuso, E.
    Villa, A.
    Merelli, I.
    Di Micco, R.
    Kajaste-Rudnitski, A.
    Montini, E.
    Lombardo, A.
    Genovese, P.
    Penaud-Budloo, M.
    Naldini, L.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A149 - A149
  • [12] PREDICTING RESPONSE TO CHEMOTHERAPY IN RECURRENT HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION ONCOLOGY PLATFORM
    Mrugala, M. M.
    Zimmerman, R.
    Greene, D.
    Fortin-Ensign, S.
    Blomquist, M.
    Swanson, K.
    Bendok, B.
    NEURO-ONCOLOGY, 2023, 25
  • [13] Energy-autonomous biosensing platform using supply-sensing CMOS integrated sensor and biofuel cell for next-generation healthcare Internet of Things
    Niitsu, Kiichi
    JAPANESE JOURNAL OF APPLIED PHYSICS, 2018, 57 (10)
  • [14] Pharmacodynamic Effects of AG-946, a Highly Potent Next-Generation Activator of Pyruvate Kinase, in Ex Vivo Treatment of Red Blood Cells from Sickle Cell Disease Patients
    Rab, Minke A. E.
    Van Dijk, Myrthe J.
    Bos, Jennifer
    van Oirschot, Brigitte A.
    Gerrits, Johan
    Kosinski, Penelope A.
    Kung, Charles
    Jans, Judith J. M.
    Van Beers, Eduard J.
    Dang, Lenny
    van Wijk, Richard
    BLOOD, 2021, 138
  • [15] Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform
    Choudhury, Yukti
    Pinweha, Pannapa
    Poh, Jonathan
    Lim, Jing Shan
    Tan, Min-Han
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [16] PREDICTING RESPONSE TO CHEMOTHERAPY IN HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION ONCOLOGY PLATFORM - A MULTI-INSTITUTIONAL EXPERIENCE
    Mrugala, Maciej
    Hrachova, Maya
    Sherman, Wendy
    Ensign, Shannon Fortin
    Blomquist, Mylan
    Porter, Alyx
    Thompson, Tracy
    Greene, Denia
    Anastasiadis, Panos
    Vasmatzis, George
    Lin, Wan-Hsin
    Dunn, Ian
    Quinones-Hinojosa, Alfredo
    Zimmerman, Richard
    Swanson, Kristin
    Bendok, Bernard
    NEURO-ONCOLOGY, 2023, 25
  • [17] Toward Genosafe Endonuclease-Boosted Gene Targeting Using Breakthrough CRISPR/Cas9 for Next Generation Stem Cell Gene Therapy Culminating in Efficient Ex Vivo/In Vivo Gene Repair/Genomic Editing
    Bertolotti, Roger
    MOLECULAR THERAPY, 2015, 23 : S139 - S139